FGF23 and anemia (phenotype): Chronic inflammation, anaemia, hypoalbuminaemia, hyperphosphataemia, arterial hypertension, and/or arterial stiffness, and high serum fibroblast growth factor 23 (FGF-23) levels were suggested as contributing factors for LVH in patients with CKD not undergoing dialysis22–25.